Illumina

Yahoo Finance • 2 days ago

Molecular Diagnostics Market Industry Trends and Global Forecasts to 2035 | Roche, Abbott, Thermo Fisher, and Illumina Among Key Players Shaping Molecular Diagnostics

Company Logo Molecular diagnostics offers rapid testing, crucial for personalized medicine and disease detection. Growth opportunities arise in segments like reagents, NGS technology, and infectious diseases. Expanding markets in Asia, ri... Full story

Yahoo Finance • 3 days ago

It isn’t your imagination; Google Cloud is flooding the zone

Image Credits:Viaframe The $100 billion partnership between Nvidia and OpenAI, announced Monday, represents – for now – the latest mega-deal reshaping the AI infrastructure landscape. The agreement involves non-voting shares tied to massi... Full story

Yahoo Finance • 6 days ago

Brown Advisory Global Leaders Strategy Exited Illumina (ILMN) in Q2. Here’s Why

Brown Advisory, an investment management company, released its “Brown Advisory Global Leaders Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy focused on delivering strong long-term p... Full story

Yahoo Finance • 13 days ago

ILMN January 2028 Options Begin Trading

Investors in Illumina Inc (Symbol: ILMN) saw new options begin trading today, for the January 2028 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 858 days unti... Full story

Yahoo Finance • 18 days ago

Europe Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Europe Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Europe... Full story

Yahoo Finance • 18 days ago

Asia-Pacific Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The... Full story

Yahoo Finance • 22 days ago

ILLUMINA INC (NASDAQ:ILMN) Screens as a Decent Value Stock for Investors

In value investing, the search for undervalued stocks often involves finding companies whose market price does not match their intrinsic worth, based on an analysis of financial health, profitability, growth potential, and valuation measur... Full story

Yahoo Finance • 26 days ago

MicroGenDX's New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions

Adoption of Illumina's MiSeq i100 Plus accelerates results delivery to next-day from sample receipt, speeding up patient care when time matters most. ORLANDO, FLORIDA / ACCESS Newswire / September 2, 2025 / MicroGenDX, a national pioneer... Full story

Yahoo Finance • 26 days ago

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others

Company Logo Liquid Biopsy MarketLiquid Biopsy Market Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (ctDNA, cfDNA, CTC), Technology (NGS, PCR), Applic... Full story

Yahoo Finance • last month

Nilesh Shah joins Illumina as Head of Region, AMEA

SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as Head of Region, AMEA, effective immediately.Nilesh Sha... Full story

Yahoo Finance • last month

Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development

Biocartis NV PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development Itasca (IL), United States, August 18th, 2025 – Biocartis Group of Companies (“Biocartis”)... Full story

Yahoo Finance • last month

Casdin funds buys Standard Biotools (LAB) shares worth $443,032

Casdin Partners Master Fund, L.P., along with other related entities, reported purchasing shares of Standard Biotools Inc. NASDAQ:LAB, totaling $443,032. The purchases, executed between August 13 and August 15, 2025, were made at prices ra... Full story

Yahoo Finance • last month

Cathie Wood's ARK ETFs make major buys in Deere & Co, Exact Sciences stock

Cathie Wood’s ARK ETF published their daily trades for Thursday, 14th August 2025, revealing a series of significant stock purchases across various sectors. Topping the list in dollar value was the acquisition of 64,789 shares of DEERE & C... Full story

Yahoo Finance • last month

BioStem Technologies Appoints Brandon Poe as Chief Financial Officer

POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived p... Full story

Yahoo Finance • 2 months ago

[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global AI in Synthetic Biology Market size & share revenue was valued at approximately USD... Full story

Yahoo Finance • 2 months ago

[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK buys Archer Aviation, sells Kratos Defense stock

Cathie Wood’s ARK ETFs have made notable moves in the market on Tuesday, 12 August 2025, with a series of buys and sells that signal the investment firm’s strategic adjustments. The most significant transaction of the day involved the sale... Full story

Yahoo Finance • 2 months ago

US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche

Company Logo The United States Personalized Medicine Market is projected to soar to US$ 307.04 billion by 2033 from US$ 169.56 billion in 2024, experiencing a CAGR of 6.82% from 2025 to 2033. Key growth drivers include advances in next-ge... Full story

Yahoo Finance • 2 months ago

Trump's trade war with China in 2025

By Liz Lee and Shi Bu BEIJING (Reuters) -U.S. President Donald Trump has targeted top economic rival China with a cascade of tariff orders on billions of dollars of imported goods aimed at narrowing a wide trade deficit, bringing back los... Full story

Yahoo Finance • 2 months ago

Standard BioTools Reports Second Quarter 2025 Financial Results

Standard BioTools Inc. SOUTH SAN FRANCISCO, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the second quarter ended June 30, 2025... Full story